Brought to you by 
MedDay receives €8mm Series A investment from InnoBio and Sofinnova
30 Apr 2013
Executive Summary
InnoBio (managed by CDC Entreprises) and Sofinnova Capital VII have participated in an €8mm ($10.5mm) Series A round for MedDay Pharmaceuticals, a 2011 start-up that is being incubated at Paris’ l’Institut du Cerveau et de la Moelle Epiniere (the Brain and Spinal Cord Institute). Chahra Louafi from CDC and Rafaele Tordjman from Sofinnova were the representatives from each investor.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
MedDay receives €8mm Series A investment from InnoBio and Sofinnova
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice